Kanani Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 12, 2025, 8:18 am

Quick Insight

Kanani Industries Ltd, operating in the Gems, Jewellery & Precious Metals industry, currently trades at a price of 1.97 with a market capitalization of 38.8 Cr. The company's P/E stands at 48.5, indicating a relatively high valuation. Despite this, the ROE and ROCE are notably low at 1.22% and 1.21% respectively, suggesting inefficiency in capital utilization. The OPM sits at 0.36%, reflecting challenges in generating profits from operations. With a healthy reserve of 45 Cr and zero borrowings, Kanani Industries appears financially stable. However, the company's CCC of 136 days may indicate potential liquidity issues. Shareholders, predominantly the public, hold 66.21% of the company, with Promoters at 33.79%. In conclusion, while Kanani Industries shows financial stability, there are concerns regarding operational efficiency and liquidity management that investors should closely monitor.

Competitors of Kanani Industries Ltd

All Competitor Stocks of Kanani Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:20 am

Below is a detailed analysis of the quarterly data for Kanani Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 83.69 Cr.. The value appears strong and on an upward trend. It has increased from 33.71 Cr. (Mar 2025) to 83.69 Cr., marking an increase of 49.98 Cr..
• For Expenses, as of Jun 2025, the value is 83.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 33.97 Cr. (Mar 2025) to 83.39 Cr., marking an increase of 49.42 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.26 Cr. (Mar 2025) to 0.30 Cr., marking an increase of 0.56 Cr..
• For OPM %, as of Jun 2025, the value is 0.36%. The value appears strong and on an upward trend. It has increased from -0.77% (Mar 2025) to 0.36%, marking an increase of 1.13%.
• For Other Income, as of Jun 2025, the value is -0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Mar 2025) to -0.01 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.01 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.29 Cr.. The value appears strong and on an upward trend. It has increased from -0.26 Cr. (Mar 2025) to 0.29 Cr., marking an increase of 0.55 Cr..
• For Tax %, as of Jun 2025, the value is 3.45%. The value appears to be increasing, which may not be favorable. It has increased from -3.85% (Mar 2025) to 3.45%, marking an increase of 7.30%.
• For Net Profit, as of Jun 2025, the value is 0.28 Cr.. The value appears strong and on an upward trend. It has increased from -0.24 Cr. (Mar 2025) to 0.28 Cr., marking an increase of 0.52 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.01. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.01, marking an increase of 0.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:32 pm

Growth

Last Updated: September 5, 2025, 8:45 am

Balance Sheet

Last Updated: June 16, 2025, 11:51 am

Below is a detailed analysis of the balance sheet data for Kanani Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 20.00 Cr..
• For Reserves, as of Mar 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 45.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 28.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 93.00 Cr.. The value appears to be improving (decreasing). It has decreased from 95.00 Cr. (Mar 2024) to 93.00 Cr., marking a decrease of 2.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 93.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2024) to 93.00 Cr., marking a decrease of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 93.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2024) to 93.00 Cr., marking a decrease of 2.00 Cr..

Notably, the Reserves (45.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Kanani Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 23) to 0.03, marking a decrease of 0.19.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.22 (Mar 23) to 0.03, marking a decrease of 0.19.
• For Cash EPS (Rs.), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 23) to 0.03, marking a decrease of 0.19.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 3.20. It has decreased from 6.33 (Mar 23) to 3.20, marking a decrease of 3.13.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 3.20. It has decreased from 6.33 (Mar 23) to 3.20, marking a decrease of 3.13.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 11.26. It has decreased from 27.34 (Mar 23) to 11.26, marking a decrease of 16.08.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has decreased from 0.33 (Mar 23) to 0.07, marking a decrease of 0.26.
• For PBIT / Share (Rs.), as of Mar 24, the value is 0.07. This value is within the healthy range. It has decreased from 0.32 (Mar 23) to 0.07, marking a decrease of 0.25.
• For PBT / Share (Rs.), as of Mar 24, the value is 0.03. This value is within the healthy range. It has decreased from 0.23 (Mar 23) to 0.03, marking a decrease of 0.20.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 0.21 (Mar 23) to 0.03, marking a decrease of 0.18.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 2. It has decreased from 0.21 (Mar 23) to 0.03, marking a decrease of 0.18.
• For PBDIT Margin (%), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 10. It has decreased from 1.22 (Mar 23) to 0.65, marking a decrease of 0.57.
• For PBIT Margin (%), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 10. It has decreased from 1.19 (Mar 23) to 0.64, marking a decrease of 0.55.
• For PBT Margin (%), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 10. It has decreased from 0.85 (Mar 23) to 0.30, marking a decrease of 0.55.
• For Net Profit Margin (%), as of Mar 24, the value is 0.27. This value is below the healthy minimum of 5. It has decreased from 0.80 (Mar 23) to 0.27, marking a decrease of 0.53.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 0.27. This value is below the healthy minimum of 8. It has decreased from 0.80 (Mar 23) to 0.27, marking a decrease of 0.53.
• For Return on Networth / Equity (%), as of Mar 24, the value is 0.97. This value is below the healthy minimum of 15. It has decreased from 3.46 (Mar 23) to 0.97, marking a decrease of 2.49.
• For Return on Capital Employeed (%), as of Mar 24, the value is 2.06. This value is below the healthy minimum of 10. It has decreased from 4.44 (Mar 23) to 2.06, marking a decrease of 2.38.
• For Return On Assets (%), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 5. It has decreased from 1.66 (Mar 23) to 0.65, marking a decrease of 1.01.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.16 (Mar 23) to 0.09, marking a decrease of 0.07.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.09. This value is within the healthy range. It has decreased from 0.50 (Mar 23) to 0.09, marking a decrease of 0.41.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.98. It has increased from 0.69 (Mar 23) to 1.98, marking an increase of 1.29.
• For Current Ratio (X), as of Mar 24, the value is 3.68. This value exceeds the healthy maximum of 3. It has increased from 2.25 (Mar 23) to 3.68, marking an increase of 1.43.
• For Quick Ratio (X), as of Mar 24, the value is 3.01. This value exceeds the healthy maximum of 2. It has increased from 1.80 (Mar 23) to 3.01, marking an increase of 1.21.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.78. This value is below the healthy minimum of 4. It has decreased from 3.29 (Mar 23) to 1.78, marking a decrease of 1.51.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 1.91. This value is below the healthy minimum of 3. It has decreased from 3.61 (Mar 23) to 1.91, marking a decrease of 1.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.81. This value is below the healthy minimum of 3. It has decreased from 3.38 (Mar 23) to 1.81, marking a decrease of 1.57.
• For Enterprise Value (Cr.), as of Mar 24, the value is 79.38. It has decreased from 82.65 (Mar 23) to 79.38, marking a decrease of 3.27.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.35. This value is below the healthy minimum of 1. It has increased from 0.30 (Mar 23) to 0.35, marking an increase of 0.05.
• For EV / EBITDA (X), as of Mar 24, the value is 54.55. This value exceeds the healthy maximum of 15. It has increased from 25.03 (Mar 23) to 54.55, marking an increase of 29.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 23) to 0.33, marking an increase of 0.12.
• For Price / BV (X), as of Mar 24, the value is 1.18. This value is within the healthy range. It has increased from 0.94 (Mar 23) to 1.18, marking an increase of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 23) to 0.33, marking an increase of 0.12.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness